A detailed history of Nuveen Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 11,097,106 shares of ABT stock, worth $1.28 Billion. This represents 0.37% of its overall portfolio holdings.

Number of Shares
11,097,106
Previous 10,845,524 2.32%
Holding current value
$1.28 Billion
Previous $1.13 Billion 12.27%
% of portfolio
0.37%
Previous 0.34%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $25.2 Million - $29.7 Million
251,582 Added 2.32%
11,097,106 $1.27 Billion
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $4.7 Million - $5.25 Million
-46,670 Reduced 0.43%
10,845,524 $1.13 Billion
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $161 Million - $178 Million
-1,473,948 Reduced 11.92%
10,892,194 $1.24 Billion
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $25.8 Million - $31.6 Million
286,258 Added 2.37%
12,366,142 $1.36 Billion
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $48.2 Million - $57.8 Million
-504,217 Reduced 4.01%
12,079,884 $1.17 Billion
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $52.1 Million - $58 Million
516,810 Added 4.28%
12,584,101 $1.37 Billion
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $47.7 Million - $56.1 Million
492,031 Added 4.25%
12,067,291 $1.22 Billion
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $58.4 Million - $68.6 Million
614,693 Added 5.61%
11,575,260 $1.27 Billion
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $26.5 Million - $30.7 Million
-274,367 Reduced 2.44%
10,960,567 $1.06 Billion
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $93.4 Million - $113 Million
914,709 Added 8.86%
11,234,934 $1.22 Billion
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $131 Million - $160 Million
-1,149,088 Reduced 10.02%
10,320,225 $1.26 Billion
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $186 Million - $228 Million
1,609,489 Added 16.32%
11,469,313 $1.61 Billion
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $152 Million - $168 Million
1,304,306 Added 15.25%
9,859,824 $1.16 Billion
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $28.8 Million - $34 Million
-272,703 Reduced 3.09%
8,555,518 $992 Million
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $59.5 Million - $70.1 Million
-546,646 Reduced 5.83%
8,828,221 $1.06 Billion
Q4 2020

May 17, 2021

SELL
$105.0 - $114.42 $1.41 Million - $1.54 Million
-13,475 Reduced 0.14%
9,374,867 $1.03 Billion
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $1.86 Million - $2.02 Million
17,673 Added 0.19%
9,388,342 $1.03 Billion
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $66.9 Million - $81.2 Million
-729,924 Reduced 7.23%
9,370,669 $1.02 Billion
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $30.9 Million - $39.5 Million
403,277 Added 4.16%
10,100,593 $923 Million
Q1 2020

May 14, 2020

SELL
$62.82 - $91.86 $80.4 Million - $118 Million
-1,280,522 Reduced 11.66%
9,697,316 $765 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $60.4 Million - $67.2 Million
-769,059 Reduced 6.55%
10,977,838 $954 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $51.6 Million - $56 Million
-631,047 Reduced 5.1%
11,746,897 $983 Million
Q2 2019

Aug 15, 2019

BUY
$72.88 - $85.0 $891 Million - $1.04 Billion
12,222,999 Added 7888.6%
12,377,944 $1.04 Billion
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $98,535 - $119,129
-1,488 Reduced 0.95%
154,945 $12.4 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $110,927 - $125,664
-1,692 Reduced 1.07%
156,433 $11.3 Million
Q3 2018

Nov 13, 2018

BUY
$60.81 - $73.36 $379,758 - $458,133
6,245 Added 4.11%
158,125 $11.6 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $1.99 Million - $2.19 Million
34,545 Added 29.44%
151,880 $9.26 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $10,128 - $11,451
-180 Reduced 0.15%
117,335 $7.03 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $37,683 - $40,343
-702 Reduced 0.59%
117,515 $0
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $5.68 Million - $6.34 Million
118,217
118,217 $6.31 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.